In clinical trials of tirzepatide, people have lost an average 20% or more of their baseline weight.
Much like with semaglutide, though, scientists have been curious about how tirzepatide might affect peoples overall health.
This new research waspublishedMonday in the journal Hypertension.
A digital blood pressure device.Image: Rich Graessle (AP)
The findings line up with similar research on semaglutide, aka Ozempic/Wegovy.
Another study later that Septemberfoundthat heart failure patients with obesity improved significantly after taking semaglutide.
News from the future, delivered to your present.
Does Ozempic Burn Fat or Just Reduce Appetite?
